Shareholding disclosure

Oliver R. Baumann

Declared position

8.4%

Threshold

Crossed upwards

Timeline

Published

22.02.2022

Transaction

11.02.2022

Voting rights breakdown

Voting rights acquired8.4%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM2L00043

Beneficial owner

Oliver R. Baumann

Declared address

Oliver R. Baumann, Zumikon

Kotierung der Aktien an der Six Swiss Exchange

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Oliver R. Baumann

Xlife Sciences AG22.02.2022TAM2L00043

Disclosure summary

Oliver R. Baumann disclosed a holding in Xlife Sciences AG on the acquisition side, published by SIX Exchange Regulation on 22.02.2022, at 8.4% of voting rights. Notice category: Single shareholder.

Disclosed position

8.4%

Voting rights acquired

Voting rights acquired8.4%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Oliver R. Baumann disclosed a holding in Xlife Sciences AG, published on 22.02.2022.

Publication date22.02.2022

Transaction date11.02.2022

Issuing companyXlife Sciences AG

Beneficial ownerOliver R. Baumann

Declared addressOliver R. Baumann, Zumikon

CategorySingle shareholder

Voting rights acquired8.4%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAM2L00043

Conditions

Kotierung der Aktien an der Six Swiss Exchange

Source: SIX Exchange Regulation · Publication date: 22.02.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open